angiotensin ii has been researched along with propofol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Jimi, N; Minami, K; Sata, T; Segawa, K; Shigematsu, A | 1 |
| Lagerkranser, M; Sollevi, A; Stånge, K | 1 |
| Bouillier, H; Dagher, G; Marty, J; Safar, M; Samain, E | 1 |
| Bouillier, H; Clichet, A; Dagher, G; Marty, J; Pili-Floury, S; Renaud, JF; Safar, M; Samain, E | 1 |
| Yang, L; Yao, SL; Zou, XJ | 1 |
| Resende, AC; Silva, GA; Soares de Moura, R; Tano, T | 1 |
| Chen, CH; Chen, YL; Cheng, TH; Cheung, CW; Leung, YM; Wong, KL | 1 |
| Chen, J; Chen, W; Tan, Z; Yin, H; Zhu, M; Zhu, Y | 1 |
| Kimoto, Y; Kuriyama, T; Ogawa, K; Tange, K; Tokinaga, Y | 1 |
| Chen, J; Miao, C; Sun, X; Sun, Z; Wang, J; Wen, M; Zhu, M | 1 |
| Deng, F; Feng, D; Hu, Z; Liang, J; Lu, Y; Wang, J; Yang, Y; Zhang, L | 1 |
| Chen, J; Chen, W; Ding, X; Ju, X; Lu, Y; Miao, C; Wang, J | 1 |
| Adhikary, S; Bonavia, A; Budde, A; Kunselman, A; Lyn-Sue, J; Mets, B; Verbeek, T | 1 |
| Franzén, S; Frithiof, R | 1 |
| Guo, K; Tang, Y; Yan, JH | 1 |
| Freed, JK; Hockenberry, JC; Katunaric, B; Pagel, PS; Schulz, ME | 1 |
1 trial(s) available for angiotensin ii and propofol
| Article | Year |
|---|---|
A randomized controlled trial comparing methohexital and propofol for induction in patients receiving angiotensin axis blockade.
Topics: Aged; Anesthesia; Anesthetics, Intravenous; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Epinephrine; Feasibility Studies; Female; Humans; Hypertension; Hypotension; Male; Methohexital; Middle Aged; Norepinephrine; Propofol | 2019 |
15 other study(ies) available for angiotensin ii and propofol
| Article | Year |
|---|---|
Inhibitory effect of the intravenous anesthetic, ketamine, on rat mesangial cell proliferation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Anesthetics, Intravenous; Angiotensin II; Animals; Cell Count; Cell Division; Cells, Cultured; Cyclic AMP; Cytokines; Depression, Chemical; Glomerular Mesangium; Ketamine; Male; Propofol; Protein Kinase Inhibitors; Rats; Rats, Wistar; Thymidine | 1997 |
Effects of propofol on cerebral blood flow, metabolism, and cerebral autoregulation in the anesthetized pig.
Topics: Anesthetics, Intravenous; Angiotensin II; Animals; Blood Pressure; Brain; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Homeostasis; Oxygen Consumption; Propofol; Regional Blood Flow; Swine; Vascular Resistance | 1997 |
The effect of propofol on angiotensin II-induced Ca(2+) mobilization in aortic smooth muscle cells from normotensive and hypertensive rats.
Topics: Anesthetics, Intravenous; Angiotensin II; Animals; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Hypertension; Male; Muscle, Smooth, Vascular; Propofol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thapsigargin | 2000 |
Effect of propofol on vasoconstriction and calcium mobilization induced by Angiotensin II differs in aortas from normotensive and hypertensive rats.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium; Dose-Response Relationship, Drug; Hypertension; Hypnotics and Sedatives; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Propofol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Cytoprotection; Extracellular Signal-Regulated MAP Kinases; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Propofol; Rats; Rats, Wistar; Reactive Oxygen Species | 2008 |
Effect of propofol on human fetal placental circulation.
Topics: Adult; Anesthetics, Intravenous; Angiotensin II; Blood Pressure; Bradykinin; Calcium Channel Blockers; Calcium Channels; Dinoprost; Dose-Response Relationship, Drug; Female; Fetus; Humans; In Vitro Techniques; Placenta; Potassium Chloride; Pregnancy; Propofol; Pulmonary Circulation; Regional Blood Flow; Vasoconstriction | 2010 |
Propofol depresses angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Topics: Anesthetics, Intravenous; Angiotensin II; Animals; Antimetabolites; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cell Survival; DNA, Complementary; Fibroblasts; Fluoresceins; Myocytes, Cardiac; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Nitrites; Oxidation-Reduction; Propofol; Rats; Rats, Sprague-Dawley; RNA; Superoxides; Transfection | 2010 |
Propofol attenuates angiotensin II-induced apoptosis in human coronary artery endothelial cells.
Topics: Anesthetics, Intravenous; Angiotensin II; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspases; Coronary Vessels; DNA Fragmentation; Endothelial Cells; Enzyme Activation; Humans; In Situ Nick-End Labeling; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Propofol; Superoxides; Vasoconstrictor Agents | 2011 |
Propofol attenuates angiotensin II-induced vasoconstriction by inhibiting Ca2+-dependent and PKC-mediated Ca 2+ sensitization mechanisms.
Topics: Anesthetics, Intravenous; Angiotensin II; Animals; Aorta, Thoracic; Calcium; Drug Interactions; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Myofibrils; Phosphorylation; Propofol; Protein Kinase C; Rats; Rats, Wistar; Vasoconstriction | 2012 |
Propofol protects against angiotensin II-induced mouse hippocampal HT22 cells apoptosis via inhibition of p66Shc mitochondrial translocation.
Topics: Angiotensin II; Animals; Apoptosis; Caspase 3; Cells, Cultured; Cytochromes c; Enzyme Activation; Enzyme Induction; Gene Expression Regulation; Hippocampus; Mice; Mitochondria; Neuroprotective Agents; NIMA-Interacting Peptidylprolyl Isomerase; Oxidative Stress; Peptidylprolyl Isomerase; Propofol; Protein Kinase C beta; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Transport; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Superoxides | 2014 |
Propofol prevents human umbilical vein endothelial cell injury from Ang II-induced apoptosis by activating the ACE2-(1-7)-Mas axis and eNOS phosphorylation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peptidyl-Dipeptidase A; Propofol; Protective Agents; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2018 |
Angiotensin II-mediated suppression of synaptic proteins in mouse hippocampal neuronal HT22 cell was inhibited by propofol: role of calcium signaling pathway.
Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Cell Line; Hippocampus; Mice; NADPH Oxidases; Neurons; Neuroprotective Agents; Oxidative Stress; Propofol; Receptor, Angiotensin, Type 1; Superoxides | 2018 |
Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs.
Topics: Anesthetics, Intravenous; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Female; Hypotension; Kidney; Losartan; Male; Oxygen; Preoperative Care; Propofol; Recovery of Function; Renal Circulation; Swine; Vasoconstriction | 2020 |
Evaluation of Propofol in Inhibiting Proliferation of Cardiac Fibroblasts in Angiotensin II-Induced Mouse.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Fibroblasts; Fibronectins; Mice; Myocardium; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Propofol; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Specific Pathogen-Free Organisms | 2021 |
Blockade of endothelial Mas receptor restores the vasomotor response to phenylephrine in human resistance arterioles pretreated with captopril and exposed to propofol.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Captopril; Humans; Hypotension; Phenylephrine; Propofol | 2022 |